Based on the CHOzen® cell line
Fucosyltransferase 8 Knockout Engineered Cell LineThe knockout technology has completed FTO(Freedom to Operate) analysis, with a clear IPposition and global licensing to ensurecommercialization safety
The titer of fed-batch culture can reach 9 g/L perbatch
Production stability complies with GMP requirements
N-glycan core fucosylation is undetectable in therecombinant mAb
中文
